sulforaphane has been researched along with Psychoses in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Zhang, T | 1 |
| Xu, L | 1 |
| Wei, Y | 1 |
| Tang, Y | 1 |
| Hu, Q | 1 |
| Liu, X | 1 |
| Li, X | 1 |
| Davis, J | 1 |
| Smith, R | 1 |
| Jin, H | 1 |
| Wang, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial)[NCT03932136] | Phase 3 | 300 participants (Anticipated) | Interventional | 2019-07-14 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sulforaphane and Psychoses
| Article | Year |
|---|---|
Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial.
Topics: Double-Blind Method; Humans; Isothiocyanates; Multicenter Studies as Topic; Prodromal Symptoms; Psyc | 2021 |